Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 55486-09-4 | MDL No. : | MFCD03788700 |
Formula : | C11H16N2O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YHRRPHCORALGKQ-FDDDBJFASA-N |
M.W : | 272.25 | Pubchem ID : | 191372 |
Synonyms : |
|
Chemical Name : | 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.64 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 63.97 |
TPSA : | 113.78 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -9.23 cm/s |
Log Po/w (iLOGP) : | 1.46 |
Log Po/w (XLOGP3) : | -1.79 |
Log Po/w (WLOGP) : | -2.21 |
Log Po/w (MLOGP) : | -2.05 |
Log Po/w (SILICOS-IT) : | -0.43 |
Consensus Log Po/w : | -1.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.44 |
Solubility : | 99.8 mg/ml ; 0.366 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.08 |
Solubility : | 225.0 mg/ml ; 0.826 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.34 |
Solubility : | 125.0 mg/ml ; 0.458 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 4.13 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In pyridine; methanol; dichloromethane; acetonitrile; | ii. 5'-O-Dimethoxytriphenylmethyl-<strong>[55486-09-4]2'-O-methyl-5-methyluridine</strong> Crude 2'-O-methyl-5-methyl uridine (12 g) was coevaporated in pyridine (2*50 mL) and dissolved in dry pyridine (50 mL). Dimethoxytriphenylmethyl chloride (18.1 g, 0.054 mol) was added. the flask was stoppered and allowed to stand for 45 min at room temperature. Methanol (10 mL) was added to quench the reaction and the solution was concentrated under reduced pressure to an oil. The residue was partitioned between ethyl acetate (2*400 mL) and saturated sodium bicarbonate solution (500 mL). The organic layers were combined, dried (sodium sulfate), filtered and concentrated to a yellow foam. The foam was dissolved in methylene chloride (60 mL) and put onto a silica gel column (300 g) and eluted with ethyl acetate-hexanes-triethylamine, 60:40:1. The product containing fractions were combined, concentrated and coevaporated with dry acetonitrile (2*50 mL). The resulting residue was dried at 1 mm Hg for 24 h to a crisp white foam, 17.0 g (60.4% in three steps from 5-methyluridine). | |
In pyridine; methanol; dichloromethane; acetonitrile; | EXAMPLE 21 5'-O-Dimethoxytriphenylmethyl-<strong>[55486-09-4]2'-O-methyl-5-methyluridine</strong> Crude 2'-O-methyl-5-methyl uridine (12 g) was coevaporated in pyridine (2*50 mL) and dissolved in dry pyridine (50 mL). Dimethoxytriphenylmethyl chloride (18.1 g, 0.054 mol) was added the flask was stoppered and allowed to stand for 45 min at room temperature. Methanol (10 mL) was added to quench the reaction and the solution was concentrated under reduced pressure to an oil. The residue was partitioned between ethyl acetate (2*400 mL) and saturated sodium bicarbonate solution (500 mL). The organic layers were combined, dried (sodium sulfate), filtered and concentrated to a yellow foam. The foam was dissolved in methylene chloride (60 mL) and put onto a silica gel column (300 g) and eluted with ethyl acetate-hexanes-triethylamine, 60:40:1. The product containing fractions were combined, concentrated and coevaporated with dry acetonitrile (2*50 mL). The resulting residue was dried at 1 mm Hg for 24 h to a crisp white foam, 17.0 g (60.4% in three steps from 5-methyluridine). | |
In pyridine; methanol; dichloromethane; acetonitrile; | EXAMPLE 21 5'-O-Dimethoxytriphenylmethyl-<strong>[55486-09-4]2'-O-methyl-5-methyluridine</strong> Crude 2'-O-methyl-5-methyl uridine (12 g) was coevaporated in pyridine (2*50 mL) and dissolved in dry pyridine (50 mL). Dimethoxytriphenylmethyl chloride (18.1 g, 0.054 mol) was added. the flask was stoppered and allowed to stand for 45 min at room temperature. Methanol (10 mL) was added to quench the reaction and the solution was concentrated under reduced pressure to an oil. The residue was partitioned between ethyl acetate (2*400 mL) and saturated sodium bicarbonate solution (500 mL). The organic layers were combined, dried (sodium sulfate), filtered and concentrated to a yellow foam. The foam was dissolved in methylene chloride (60 mL) and put onto a silica gel column (300 g) and eluted with ethyl acetate-hexanes-triethylamine, 60:40:1. The product containing fractions were combined, concentrated and coevaporated with dry acetonitrile (2*50 mL). The resulting residue was dried at 1 mm Hg for 24 h to a crisp white foam, 17.0 g (60.4% in three steps from 5-methyluridine). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.06 g (49%) | Example 27 2'-O-Methyl-5'-O -phthalimido-5-methyluridine (13a) <strong>[55486-09-4]2'-O-Methyl-5-methyluridine</strong> (4.08 g, 15 mmol) was reacted according to general procedure B. After the reaction was complete (by TLC), the solids were collected, washed well with ether, and dried to yield 3.06 g (49%) of pure product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
EXAMPLE 8 2'-O-Methyl-5-methyluridine. 3,5-Di-O-benzoyl-2'-O-methyl-5-methyluridine (14.3 g, 30 mmoles) was dissolved in methanol (130 ml) and concentrated ammonium hydroxide (65 ml) for 24 hours. The solvent was evaporated under reduced pressure and the residue was triturated with ether to give 6.5 g (80%) of white solid. An analytical sample was crystallized from absolute ethanol to afford 2'-O-methyl-5-methyluridine as white needles, mp 192-193 C. (lit., E. Ootsuka, H. Inoue, Japanese Patent 89-85456, 4 Apr. 1989, mp 197-198 C.). 1 H NMR (DMSO-d6): delta1.79 (s, 3H, 5-CH3), 3.35 (s, 3H, OCH3), 3.5-3.7 (m, 2H, H-5'), 3.7-3.9(m, 2H, H-3',4'), 4.15 (m, 1H, H-2'), 5.17 (m, 2H, 3',5'--OH), 5.87 (d, J= 5 Hz, 1H, H-1'), 7.80 (s, 1H, H-6), 11.37 (br s, 1H, N--H). Anal. Calcd for C11 H16 N2 O6 (272.26): C, 48.52; H, 5.92; N, 10.29. Found: C, 48.56; H, 5.88; N, 10.22. | ||
The synthetic mRNA construct of claim 1, wherein the mRNA construct comprises one or more chemically-modified nucleotides selected from the group of 5-hydroxyuridine, 5-methyluridine, 5,6-dihydro-5-methyluridine, 2'-O-methyluridine, 2'-O-methyl-5-methyluridine, 2'-fluoro-2'-deoxyuridine, 2'-amino-2'-deoxyuridine, 2'-azido-2'-deoxyuridine, 4-thiouridine, 5-hydroxymethyluridine, 5-carboxyuridine, 5-carboxymethylesteruridine, 5-formyluridine, 5-methoxyuridine, 5-propynyluridine, 5-bromouridine, 5-iodouridine, 5-fluorouridine;pseudouridine, 2'-O-methyl-pseudouridine, N1-hydroxypseudouridine, N1-methylpseudouridine, 2'-O-methyl-N1-methylpseudouridine, N1-ethylpseudouridine, N1-hydroxymethylpseudouridine, and Arauridine;5-hydroxycytidine, 5-methylcytidine, 5-hydroxymethylcytidine, 5-carboxycytidine, 5-formylcytidine, 5-methoxycytidine, 5-propynylcytidine, 2-thiocytidine;5-hydroxyuridine, 5-methyluridine, 5,6-dihydro-5-methyluridine, 2'-O-methyluridine, 2'-O-methyl-5-methyluridine, 2'-fluoro-2'-deoxyuridine, 2'-amino-2'-deoxyuridine, 2'-azido-2'-deoxyuridine, 4-thiouridine, 5-hydroxymethyluridine, 5-carboxyuridine, 5-carboxymethylesteruridine, 5-formyluridine, 5-methoxyuridine, 5-propynyluridine, 5-bromouridine, 5-iodouridine, 5-fluorouridine;N6-methyladenosine, 2-aminoadenosine, 3-methyladenosine, 7-deazaadenosine, 8-oxoadenosine, inosine;thienoguanosine, 7-deazaguanosine, 8-oxoguanosine, and 6-O-methylguanine. |